吉林男科医院治疗早泄去哪家吉林泌尿感染专科医院,吉林切包皮过长切除要多少钱,吉林哪个医院治疗早泄治疗好,吉林前列腺炎分型疗法,吉林那家医院治支原体感染好,吉林那些医院治疗早泄比较好,吉林慢性前列腺炎费用多少

LOS ANGELES, March 27 (Xinhua) -- Walnuts have a combination of more healthful antioxidants and higher quality antioxidants than any other nut, U.S. researchers have found.Study findings were presented on Sunday at the 241st National Meeting & Exposition of the American Chemical Society (ACS) in Anaheim, Southern California.Nuts contain plenty of high-quality protein that can substitute for meat, vitamins and minerals, dietary fiber, and are dairy- and gluten-free, ACS researchers said in the study.Moreover, nuts contain healthful polyunsaturated and monosaturated fats rather than artery-clogging saturated fat, according to the study.The researchers based their conclusion on analysis of antioxidants in nine different types of nuts: walnuts, almonds, peanuts, pistachios, hazelnuts, Brazil nuts, cashews, macadamias and pecans.They found that walnuts have the highest levels of antioxidants, with plenty of high-quality protein that can substitute for meat, vitamins and minerals, dietary fiber, and are dairy- and gluten-free.The latest study adds more evidence that walnuts are top nuts for heart-healthy antioxidants, the researchers said.Previous studies showed that regular consumption of small amounts of nuts or peanut butter can decrease the risk of heart disease, certain kinds of cancer, gallstones, Type 2 diabetes, and other health problems.But the latest study is the first to compare both the amount and quality of antioxidants found in different nuts."Walnuts rank above peanuts, almonds, pecans, pistachios and other nuts," said Joe Vinson, Ph.D., who led the latest study."A handful of walnuts contains almost twice as much antioxidants as an equivalent amount of any other commonly consumed nut. But unfortunately, people don't eat a lot of them. This study suggests that consumers should eat more walnuts as part of a healthy diet."

WASHINGTON, May 20 (Xinhua) -- The U.S. Food and Drug Administration (FDA) on Friday approved Sutent to treat patients with progressive neuroendocrine cancerous tumors located in the pancreas that cannot be removed by surgery or that have spread to other parts of the body.Neuroendocrine tumors found in the pancreas are slow-growing and rare. It is estimated that there are fewer than 1,000 new cases in the United States each year.This is the second new approval by the FDA to treat patients with this disease. On May 5, the agency approved Afinitor."FDA believes it is important to provide cancer patients with as many treatment options as possible," said Richard Pazdur, director of the Office of Oncology Drug Products in the FDA's Center for Drug Evaluation and Research. "The agency is committed to working with companies to bring innovative new therapies to the market and encourages companies to continue exploring additional uses for approved products."The safety and effectiveness of Sutent was established in a single study of 171 patients with metastatic (late-stage) or locally advanced (disease that could not be removed with surgery) disease who received Sutent or a placebo (sugar pill). The study was designed to measure the length of time a patient lived before their disease spread or worsened (progression-free survival).Results from the study demonstrate that Sutent provided benefit to patients by prolonging the median length of time they lived without the cancer spreading or worsening to 10.2 months compared to 5.4 months for patients who received placebo.In patients treated with Sutent for neuroendocrine pancreatic tumors, the most commonly reported side effects included diarrhea, nausea, vomiting, fatigue, anorexia, high blood pressure, energy loss, stomach pain, changes in hair color, inflammation of the mouth, and a decrease in infection-fighting white blood cells.Sutent is marketed by New York City-based Pfizer.

TOKYO, March 20 (Xinhua) -- Traces of radioactive iodine had been detected in Tokyo and the surrounding Kanto region, according to the results of an investigation of radioactivity in precipitation and dust conducted by the government, local media reported on Sunday.Radioactive iodine was found in Tokyo, Saitama, Chiba, Yamanashi, Tochigi and Gunma prefectures, the Kyodo News said, citing the Ministry of Education, Culture, Sports, Science and Technology. The ministry added that the levels detected in the investigation alone would not affect human health.An employee of Yamagata city office holds a Geiger counter to detect radiation when evacuees from the vicinity of Fukushima nuclear plant wish to be screened upon their arrival at an evacuation centre set in a gymnasium in Yamagata, northern Japan March 19, 2011, eight days after Japan's devastating earthquake and tsunami.The investigation was carried out following the nuclear crisis at the Fukushima Daiichi nuclear power plant, the government said Sunday.The ministry said that a separate research has already shown that radioactive materials in the air and tap water in Tokyo and the five prefectures pose no threat to human health, according to Kyodo News report.

MOSCOW, April 22 (Xinhua) -- The Russian Space Forces has re-established contact with a military satellite, Geo-IK-2, which went missing in February, local media reported Friday.According to a spokesman from the Defense Ministry, Interfax news agency said the Space Forces had already received telemetric information from the satellite and collection and analysis of the data were currently underway.After studying the information, the Defense Ministry would make a decision regarding the further use of the satellite, the spokesman said.A Rokot light-class carrier rocket carrying with the Geo-IK-2 satellite blasted off Feb. 1 from Russia's Plesetsk launching site, but placed the satellite in an incorrect orbit. After the launch, the Defense Ministry announced it had lost contact with the Geo-IK-2 and later abandoned the satellite.The Russian Space Forces then grounded launches of all Rokot light-class carrier rockets until the completion of an investigation into the failed launch.

BEIJING, March 29 (Xinhuanet) -- Tickets for Apple's annual World Wide Developer Conference (WWDC) 2011 have already been sold out ten hours after the event was announced Monday, according to media reports.It is the first time the event sold out the same day it was announced. Last year, the conference sold out in eight days.WWDC 2011, with the tickets priced at 1599 U.S. dollars, will run from June 6 till June 10 at the Moscone West conference center in San Francisco.This year's speedy turnaround is probably because of a rumored double-focus on iOS and Mac OS."At this year's conference we are going to unveil the future of iOS and Mac OS," Philip Schiller, Apple's senior vice president of Worldwide Product Marketing, said in a press release."If you are an iOS or Mac OS X software developer, this is the event that you do not want to miss."The event will feature more than 100 technical sessions presented by Apple engineers on Application Frameworks; Graphics, Media and Games; Developer Tools; Internet and Web, and Core OS.